Anti-rheumatic medications lessen the incidence of diabetes

Studies performed on arthritis and psoriasis patients reveal that anti-rheumatic drugs are capable of majorly lowering the risk of diabetes. These drugs trigger the tumor necrosis factor (TNF) inhibitors and therefore improve the metabolism of insulin and glucose in the body. This finding can primarily help the individuals with a family background of diabetes mellitus. Anti-rheumatic medications have been suggested as a part of preventive therapy for diabetes prone individuals by many scientists.